AL101: Clinical Trials

2 trials of AL101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow AL101: new trials by email Literature Review of AL101 trials Research Report on AL101

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer
AL101 - Triple Negative Breast Cancer
Phase 2TerminatedAyala Pharmaceuticals, Inc,182020-08-142024-02-12
A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations
AL101 - Adenoid Cystic Carcinoma
Phase 2CompletedAyala Pharmaceuticals, Inc,872018-12-142024-01-31

Conditions studied

Carcinoma, Adenoid Cystic (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

Ayala Pharmaceuticals, Inc, (2)

Countries

Israel (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

Andres Gutierrez, MD, PhD (1)